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ABSTRACT
TDP-43 is a pathogenic protein: its normal function
in binding to UG-rich RNA is related to cystic fibro-
sis, and inclusion of its C-terminal fragments in
brain cells is directly linked to frontotemporal lobar
degeneration (FTLD) and amyotrophic lateral sclero-
sis (ALS). Here we report the 1.65A ˚ crystal structure
of the C-terminal RRM2 domain of TDP-43 in com-
plex with a single-stranded DNA. We show that
TDP-43 is a dimeric protein with two RRM domains,
both involved in DNA and RNA binding. The crystal
structure reveals the basis of TDP-43’s TG/UG pref-
erence in nucleic acids binding. It also reveals that
RRM2 domain has an atypical RRM-fold with an
additional b-strand involved in making protein–
protein interactions. This self association of RRM2
domains produced thermal-stable RRM2 assem-
blies with a melting point greater than 858Ca s
monitored by circular dichroism at physiological
conditions. These studies thus characterize the rec-
ognition between TDP-43 and nucleic acids and the
mode of RRM2 self association, and provide molec-
ular models for understanding the role of TDP-43 in
cystic fibrosis and the neurodegenerative diseases
related to TDP-43 proteinopathy.
INTRODUCTION
Proteins constitute and carry out all kinds of intra- and
extra-cellular events and therefore mutations, deletions,
misfolding and aggregation of protein molecules, leading
to gain or loss of protein functions, are related to numer-
ous genetic and sporadic diseases. TAR DNA-binding
protein 43 (TDP-43) is a ubiquitously expressed protein
whose normal function and abnormal aggregation
are directly linked to the common lethal genetic disease,
cystic ﬁbrosis (1) and to two neurodegenerative
disorders: frontotemporal lobar degeneration (FTLD)
and amyotrophic lateral sclerosis (ALS) (2,3).
TDP-43 was originally identiﬁed as a transcriptional
factor, repressing the transcription of HIV-1 gene (4),
mouse SP-10 gene (5), and the expression of human
cyclin-dependent kinase 6 (Cdk6) (6). TDP-43 is also a
splicing factor binding to the intron 8/exon 9 junction of
the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) gene (7–9), and the intron 2/exon 3 junction of
apoA-II gene (10) to inhibit exon splicing. The binding
of TDP-43 to the UG-repeats located at the 30-splice site
of CFTR intron 8 leads to exon 9 skipping and the tran-
scription of a shorter transcript, resulting in the expression
of an inactive CFTR protein in cystic ﬁbrosis patients
(11). Moreover, TDP-43 has also been shown to be a
human low molecular weight neuroﬁlament (hNFL)
mRNA-binding protein in spinal motor neurons (12),
and a neuronal activity-responsive factor in the dendrites
of hippocampal neurons (13), suggesting its involvement
in regulating mRNA stability, transport and local trans-
lation in neurons. Therefore, TDP-43 is both a DNA-
binding and a RNA-binding protein, bearing multiple
functions in transcriptional repression, pre-mRNA
splicing and translational regulation.
Recently, breakthrough studies showed that TDP-43 is
the major disease protein in the pathogenesis of both
FTLD with ubiquitin inclusions and ALS (14,15).
FTLD, referring to a heterogeneous group of neurodegen-
erative disorders, is the second most common form
of presenile dementia after Alzheimer’s disease (3).
FTLD with ubiquitin-positive, tau-negative inclusions
(FTLD-U) accounts for 60% of the phenotypes associated
with FTLD syndromes. ALS is the most common adult-
onset motor neuron disease, and in common with FTLD,
has similar ubiquitinated inclusions in the surviving motor
cells (16). TDP-43 was identiﬁed as the major compo-
nent protein in the ubiquitinated inclusions in both
FTLD-U and ALS disorders. Pathological TDP-43 in
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phosphorylated, ubiquitinated and cleaved to  25kDa
C-terminal fragments in aﬀected brain regions. These
abnormal aggregates of phosphorylated and ubiquitinated
TDP-43 thus deﬁne a new group of neurodegenerative
diseases, the TDP-43 proteinopathies (3,17,18). Missense
mutations have now been identiﬁed in gene encoding
TDP-43, TARDBP, in familial and sporadic ALS, provid-
ing further evidence of a direct link between TDP-43 func-
tion and neurodegeneration (16,19,20). Among the unique
features of TDP-43 inclusions are that they are not
amyloid deposits, and are negative for tau, a-synuclein,
b-amyloid and expanded polyglutamines, indicating that
they might have a distinct aggregated structure.
The TARDBP gene is highly conserved in human,
mouse, Drosophila melanogaster and Caenorhabditis
elegans (21). Sequence analysis identiﬁed two RNA-
recognition motifs, RRM1 and RRM2, and a C-terminal
glycine-rich domain in TDP-43 (Figure 1), similar to the
domain organization of heterogeneous nuclear ribonu-
cleoproteins (hnRNP) family proteins such as hnRNP
A1 and A2/B1 (22). RRMs are common RNA-binding
motifs, with two highly conserved hexameric and octa-
meric segments denoted respectively as ribonucleoprotein
2 (RNP2) and ribonucleoprotein 1 (RNP1) (23). The con-
served RNP segments in TDP-43 are involved in binding
to TAR DNA sequences (4) and RNA sequences with
UG-repeats (8,24). The glycine-rich C-terminal tail of
TDP-43 can interact with the hnRNP family proteins to
form the hnRNP-rich complex involved in splicing inhibi-
tion (25). Mutation analyses further suggest that the
TDP-43 glycine-rich domain is essential for the CFTR
exon 9-skipping activity (21,24,25).
Although TDP-43 is involved in diverse transcriptional
and splicing events, and plays a key role in the pathologies
of neurodegenerative diseases, its biochemical properties,
molecular structure, domain assembly and DNA/RNA
recognition mechanism are largely unknown. Here we
report the crystal structure of a TDP-43 RRM2 domain
in complex with a single-stranded DNA and demonstrate
the basis of its TG/UG preference. The RRM2 domain
has an atypical RRM-fold with an additional b-strand
Figure 1. Domain structures and assembly of TDP-43 proteins. (A) TDP-43 has two RRM domains, RRM1 and RRM2, and a C-terminal glycine-
rich domain. In this study, three truncated TDP-43 proteins were constructed: TDP-43s, RRM1 and RRM2. (B) Amino-acid sequences of mouse and
human TDP-43 in the RRM1 and RRM2 domains. The secondary structures listed above the sequences are derived from the crystal structure of
RRM2–DNA complex. (C) The purity of TDP-43 truncated proteins was assayed by 12.5% SDS–PAGE. (D) RRM2 appeared as a tetramer in
the native 20% PAGE gel. (E) Gel ﬁltration (Superdex 200) proﬁles of TDP-43 truncated proteins show that TDP-43s, RRM1 and RRM2 all
had a molecular weight of  40kDa, suggesting that the recombinant TDP-43s was a homodimer, and RRM1 and RRM2 were homotetramers.
(F) The GFP-fused TDP-43, with a molecular weight of 69kDa, was expressed in human 293T cells for size exclusion chromatography analysis.
The fractionated cell extract eluted from a Superdex 200 column were blotted by TDP-43 antibodies. GFP-TDP-43 was mainly eluted with a size of
a dimer. The molecular weight markers are: aldolase (158kDa), conalbumin (75kDa) and ovalbumin (43kDa).
1800 Nucleic Acids Research, 2009, Vol. 37,No. 6involved in making domain–domain interactions. The role
of this b-strand in forming a highly thermal-stable higher
order complex is discussed.
MATERIALS AND METHODS
Protein expression and purification
The gene fragments encoding mouse TDP-43s (residues
101–265), RRM1 (residues 101–191) and RRM2 (residues
192–265) were ampliﬁed by PCR. All of the PCR products
were digested with two restriction enzymes, BamHI and
HindIII, and then inserted into pQE30 expression vector
(Qiagen, USA) to generate the N-terminal His-tagged con-
structs. All of the truncated TDP-43 proteins were over-
expressed in Escherichia coli M15 strain. Cells were grown
in LB medium to a density of  0.5 OD600 and induced
using 0.8mM IPTG for 22h at 208C.
Cell extracts were loaded onto a Ni-NTA aﬃnity
column (Qiagen, USA) and washed with a step gradient
of buﬀer containing 0.5M imidazole, 100mM NaCl and
20mM Tris pH 7.6. Peak fractions were dialyzed against
10mM b-mercaptoethanol and 20mM Tris pH 7.6 and
then applied to a HiTrap heparin column (GE, USA).
Protein samples were eluted with a step gradient of
buﬀer containing 1M NaCl, 10mM b-mercaptoethanol
and 20mM Tris pH 7.6. The eluted proteins were dialyzed
against 5mM NaCl, 10mM b-mercaptoethanol and
20mM Tris–HCl at pH 7.6 and then puriﬁed on a
Superdex 200 gel column. The puriﬁed protein samples
were concentrated to  20mg/ml with Vivaspin ultraﬁltra-
tion unit (Sartorius, Germany).
The GFP-fused TDP-43 was expressed in human 293T
cells which were maintained as monolayers in DMEM
supplemented with 100units/ml penicillin-streptomycin
and 10% FCS (GIBCO) at 378C under 5% CO2. The
plasmid encoded GFP-TDP-43 was constructed by inser-
tion of the full-length TDP-43 cDNA into the EGFP-N3
(Promega, USA). The plasmid was transfected into 293T
cells using the calcium phosphate precipitation method.
After 12h of transfection, the medium was changed, and
the cells were further incubated for 24h. The cells extracts
were loaded into a Superdex 200 column (GE, USA) in the
buﬀer containing 50mM Tris–HCl, 400mM NaCl at
pH 7.5. The collected fractions were concentrated for
western blot analysis.
Filter bindingassay
All of the RNA (and DNA) substrates for ﬁlter-binding
assays were 50-end labeled with [g-
32P]ATP by T4 PNK.
The labeled RNA (10 pmol) was then incubated with trun-
cated proteins for 10min at room temperature in binding
buﬀer containing 20mM Tris–HCl at pH 8.0. The mixture
was ﬁltered through a BA 85 nitrocellulose membrane
(Schleicher and Schuell, USA) overlaid on a nylon mem-
brane (Roche, Germany) in a 60-well slot blot apparatus
(Bio-Rad, USA). After extensive washing, the protein–
RNA complex-bound nitrocellulose membrane and free-
RNA-bound nylon membrane were air dried and exposed
to a phosphor imaging plate. Film signals were counted
by Luminescent image analyzer LAS-1000plus (Fujiﬁlm,
Japan) and the aﬃnity was calculated using the Hill equa-
tion with three parameters. The Kd values were deduced
from the protein concentrations at which half of the RNA
substrates were protein-bound.
Circulardichroism (CD)
The thermal denaturing melting points of TDP-43
truncated proteins were measured three times by a CD
spectrometer AVIV CD400. The CD spectra were scanned
from 258Ct o8 5 8C at a wavelength of 218nm and the melt-
ing point was estimated by AVIV program. The protein
concentration was 0.1mg/ml in a buﬀer containing
300mM NaCl in 50mM phosphate buﬀer (pH 7.0).
Crystallization, structural determination and refinement
The RRM2 used for crystallization was puriﬁed with a
procedure slightly diﬀerent from the one used for bio-
chemical analysis. All the Tris–HCl buﬀer was replaced
by PBS buﬀer at pH 7.9, and 1mM DTT was added in
the last puriﬁcation step using a HiTrap heparin column.
The eluted proteins were dialyzed against 1% glycerol
and 20mM Tris–HCl at pH 7.9, and concentrated to
 6mg/ml. The puriﬁed RRM2 was mixed with a single-
stranded DNA with a sequence of 50-TTGAGCGTT-30 in
a one-to-one molar ratio. Crystals of RRM2–DNA com-
plex were grown by hanging drop vapor-diﬀusion method
at room temperature, by mixing 1ml of protein–DNA
solution with 1ml of reservoir solution containing 2M
(NH4)2SO4, 0.1M phosphate-citrate at pH 4.2. The reser-
voir solution contained an additional 10% glycerol.
The X-ray diﬀraction data were collected at beamline
13C1 of the NSRRC in Hsinchu, Taiwan at  1508C. The
data were processed and scaled by HKL2000 (26) and
all of the diﬀraction statistics are listed in Table 1. The
RRM2–DNA complex crystallized in the F222 cubic
space group, with one molecule per asymmetric unit.
The structure of the complex was solved by molecular
replacement using the NMR structure of human TDP-
43–RRM2 (PDB accession code: 1WF0) as the searching
model. After reﬁnement of the protein molecule, the struc-
ture of DNA was built as guided by the (2Fo-Fc) Fourier
maps. The structure model was then manually rebuilt with
WinCoot and reﬁned with CCP4. The data collection
and reﬁnement statistics are summarized in Table 1. The
coordinates and structural factors of the RRM2–DNA
complex have been deposited in the Protein Data Bank
with a PDB ID of 3D2W.
RESULTS
TDP-43 isadimer withfour RRMdomains
To study the biochemical properties of TDP-43, we con-
structed three truncated forms of mouse TDP-43, which
shares a high sequence identity of 96.1% with human
TDP-43 (Figure 1). TDP-43s covered both RRM domains
from residues 101–285, RRM1 covered the ﬁrst RRM
from residues 101–191, and RRM2 covered the second
RRM from residues 192–285. The three truncated forms
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expressed in E. coli and puriﬁed by chromatographic
methods using a Ni
2+-NTA agarose aﬃnity column, fol-
lowed by a HiTrap heparin and a Superdex 200 gel ﬁltra-
tion column. All three recombinant proteins had
homogeneity greater than 98% as analyzed by SDS–
PAGE (Figure 1C).
The calculated molecular weights of the truncated pro-
teins were 20659.59Da for TDP-43s, 12351.09Da for
RRM1 and 10080.45Da for RRM2. However, the gel
ﬁltration proﬁles gave molecular weights of approximately
40kDa for all of these three proteins (Figure 1E). RRM2
was further applied to a native PAGE where it appeared
as a homotetramer with a molecular weight between
40kDa and 55kDa (Figure 1D). These results show that
TDP-43s is a homodimer with four RRM domains.
On the other hand, RRM1 and RRM2 are homotetra-
mers, with four copies of the RRM in each tetrameric
assembly.
To further determine the oligomerization of TDP-43
in a cellular environment, a GFP-fused TDP-43 was
expressed in human 293T cells for size exclusion chroma-
tography analysis. The cell extract was fractionated by a
Superdex 200 gel ﬁltration column and the fractionated
eluents were blotted by TDP-43 antibodies. As shown in
Figure 1F, the GFP-TDP-43 with a molecular weight
of 69kDa was eluted mainly with a size of a dimer
( 150kDa). Small portions of the GFP-TDP-43 were
eluted as monomers ( 70kDa) and large-size aggregates.
This result thus suggests that TDP-43 forms a homodimer
in a cellular environment.
TDP-43s binds ssDNA and dsDNA withpreference for
TG-rich sequences
To ﬁnd out the DNA-binding aﬃnity of TDP-43 trun-
cated proteins, the three truncated proteins were incu-
bated with single-stranded and with double-stranded
32-mer DNA of HIV-1 TAR sequences (TAR32). The
binding aﬃnities between TDP-43 fragments and DNA
were analyzed by nitrocellulose ﬁlter-binding assays.
TDP-43s bound the single-stranded 32-mer DNA of
TAR sequence (TAR32) slightly better than the double-
stranded DNA, with a Kd of 10.6 0.2nM for ssTAR32
and 83.8 9.5nM for dsTAR32 (Figure 3). RRM1 also
bound single- and double-stranded TAR32 DNA with
comparable aﬃnities (Kd=6.2 0.6nM for ssTAR32
and 16.7 1.0nM for dsTAR32), whereas RRM2 had
one-order lower binding aﬃnities (Kd=137.5 14.8nM
for ssTAR32 and 600.5 96.8nM for dsTAR32). These
results suggest that TDP-43s binds both double-stranded
and single-stranded DNA of TAR sequences, and that
both RRM1 and RRM2 domains can bind DNA.
To ﬁnd out whether TDP-43 binds site-speciﬁcally to
TG-rich DNA sequences, we synthesized a number of
12-mer DNAs bearing either TAR sequences, TG repeats,
CA repeats or a P12 random sequence without any TG
repeats (Figure 2C). The TDP-43s Kd values for single-
stranded and double-stranded TAR and TG repeats
(ranging between 89.3nM and 147.1nM) were one to
two orders of magnitude less than those for non-TG
sequences (382.5nM for a single-stranded CA repeat and
1315nM for a double-stranded P12 random sequence).
These data suggest that TDP-43s prefers to bind to TG-
rich 12-mer DNAs with at least an order higher aﬃnity
than non-TG sequences.
TDP-43s prefers tobind UG-richRNA
A previous study showed that the GST-fused TDP-43
recombinant protein can bind a single-stranded RNA
with a minimum number of six UG repeats and the bind-
ing aﬃnity increases with the number of repeats (8). To
further quantify the binding aﬃnity of TDP-43 for RNA,
we synthesized a series of RNA nucleotides with or with-
out UG repeats of diﬀerent lengths. TDP-43s bound
single-stranded UG-repeat RNAs with high aﬃnity
[Kd=14.2 1.4nM for single-stranded (UG)6, see
Figure 3]. Consistent with previous results, TDP-43s
bound RNA with more UG-repeats with higher aﬃnity,
as evidenced by the Kd values of 3060nM for (UG)3,
115.3nM for (UG)4, 14.2nM for (UG)6 and 2.79nM for
(UG)8. These results suggest that TDP-43s can bind
single-stranded RNA with at least three UG repeats and
the binding aﬃnity increases by about one order with each
addition of two UG repeats.
The truncated mutant RRM1 bound RNA in a way
similar to that of TDP-43s. RRM1 also preferred to
bind to RNA with more UG-repeats, with a Kd of
4690nM for (UG)3 and 65.2nM for (UG)6. However,
the binding aﬃnity trend of RRM2 to UG-repeat RNA
was diﬀerent: it bound to ss(UG)3 with higher aﬃnity
(379nM) than to ss(UG)6 (4240nM). This result implies
Table 1. Crystallographic statistics of RRM2–DNA complex crystal
Data collection and processing Values
Wavelength (A ˚ ) 1.0
Space group F222
Cell dimensions (a/b/c)( A ˚ ) 41.283/87.290/125.345
Resolution (A ˚ ) 1.65
Observed reﬂections 63632
Unique reﬂections 13674
Redundancy
a 4.7 (4.5)
Completeness
a (%) 98.7 (97.0)
Rsym
a (%) 5.8 (32.5)
I/s(I)
a 22.2 (3.5)
Reﬁnement statistics
Resolution range 25.46 1.65
Reﬂections (work/test) 12633/1010
R-factor/R-free (%) 20.7/24.6
Non-hydrogen atoms
Protein 561
Solvent molecules 127
Model quality
r.m.s. deviations in
Bond length (A ˚ ) 0.009
Bond angle (8) 1.257
Average B-factor (A ˚ 2) 23.5
Ramachandran plot (%)
Most favored 93.8
Additionally allowed 6.2
Generously allowed 0
Disallowed 0
aThe last shell (1.70–1.65A ˚ ) statistics are listed in parenthesis.
1802 Nucleic Acids Research, 2009, Vol. 37,No. 6that RRM2 might have a diﬀerent conformation or a
diﬀerent tertiary structure of its domain assembly than
TDP-43s and RRM1. Moreover, the trend of binding
aﬃnity to (UG)6 RNA was: TDP-43s>RRM1>
RRM2, suggesting that both RRM domains are necessary
for achieving the best binding aﬃnity of TDP-43.
To further conﬁrm that TDP-43 prefers UG-rich
sequences, we prepared 12-mer RNAs without any UG-
repeat: a poly(U) sequence (U12) and a poly(A) sequence
(A12). Compared to 12-mer UG-repeat RNAs, the disso-
ciation constants between TDP-43s and U12 and A12 were
20–60-fold higher, in the range of 300–900nM. This result
veriﬁes that TDP-43s prefers to bind UG-rich 12-mer
RNA with at least one order higher aﬃnity than RNA
without any UG-repeats.
Overall crystal structure of RRM2–DNA complex
To reveal the molecular basis underlying the interactions
between TDP-43 and DNA/RNA, all of the truncated
forms of TDP-43 were screened for co-crystallization con-
ditions with RNA and DNA of various sequences and
lengths. Only RRM2 co-crystallized with a single-stranded
10-mer DNA (50-GTTGAGCGTT-30) with a preferred
TG binding site at the third and fourth positions
(underlined). The RRM2–DNA complex crystallized in
cubic F222 space group with one molecule per asymmet-
ric unit. The structure of the complex was solved by
molecular replacement using the NMR solution structure
of human TDP-43 RRM2 domain (PDB entry code:
1WF0, unpublished results) as the search model.
Figure 2. Binding aﬃnities of TDP-43 truncated proteins and DNA, analyzed by nitrocellulose ﬁlter-binding assays. (A) TDP-43s bound to both
single-stranded and double-stranded TAR DNA sequence (32-mer). The 50-end
32P-labeled DNA (10 pmol) was incubated with 0.01–40mM TDP-43s
and the resultant protein–DNA complexes trapped in the nitrocellulose ﬁlters were quantiﬁed. (B) Summary of the apparent dissociation constants of
TDP-43 truncated proteins and TAR 32-mer ssDNA and dsDNA. Both RRM1 and RRM2 domains were capable of DNA binding. (C) Summary of
the apparent dissociation constants of TDP-43s and various 12-mer ssDNA and dsDNA. TDP-43s prefers to bind to TG-rich 12-mer DNAs with
aﬃnity at least one order higher than non-TG sequences.
Figure 3. Binding aﬃnities of TDP-43 truncated proteins and RNA, analyzed by nitrocellulose ﬁlter-binding assays. (A) TDP-43s bound to single-
stranded RNA containing three and six UG repeats. (B) Summary of the apparent dissociation constants of TDP-43 truncated proteins and RNAs.
TDP-43s prefers to bind UG-rich 12-mer ssRNA with aﬃnity at least one order higher than RNA without any UG-repeats.
Nucleic Acids Research,2009, Vol.37, No. 6 1803The ﬁnal model contained one RRM2 molecule (residues
190–261) and nine out of ten nucleotides (T2–T10) with an
R-factor of 20.7% and an R-free of 24.6% for 63632
reﬂections up to a resolution of 1.65A ˚ .
RRM2 was a tetramer in low salt conditions, however,
RRM2 appeared as a dimer in the crystals grown
from acidic high-salt conditions. A gel ﬁltration analysis
further conﬁrmed that RRM2 indeed dissociated into
dimers under crystallization conditions of 0.1M phos-
phate-citrate and 2.0M (NH4)2SO4 at pH 4.2 (data not
shown). The ribbon model of RRM2 dimer is shown in
Figure 4A, where RRM2 molecules a and b are related to
each other by a crystallographic 2-fold symmetry. A typ-
ical RRM contains a four-stranded b-sheet (23), however,
RRM2 in TDP-43 has an additional b4 next to b5
(b2-b3-b1-b5-b4). Thus, the RRM2 has a ab sandwich
structure containing a ﬁve-stranded b-sheet packed with
two a-helices. The dimeric interface is formed mainly
through the interactions of the two antiparallel b4 strands
(residues 245–250), with a buried solvent accessible surface
area of 685A ˚ 2. Two hydrogen bonds were formed between
the main-chain atoms of Asp247 (Asp247-O to Asp247-N,
a to b and b to a), and two more hydrogen bonds
were formed between Glu245 (Oe2) and Ile249 (N) in
the two antiparallel b4 strands to stabilize the dimeric
structure (Figure 4B). The RRM2 dimer thus has an
extended b-sheet consisting of 10 antiparallel b-strands.
The RRM2 molecule (monomer a) also interacted with
another 2-fold symmetry-related RRM2 molecule
(monomer e) via b2 and a1 (Figure 4C and D). Four
hydrogen bonds (a to e and e to a) were formed between
the side-chain atoms in a1 helix: Gln209 (Ne2) to Cys212
(O), and Gln208 (Oe1) to Cys212 (Sg). The buried surface
between monomer a and e was 901A ˚ 2, slightly higher than
the interface between monomer a and b.
The single-stranded DNA was bound to the accessible
surface of the b-sheet of RRM2 with the three 50-end
nucleotides, T2, T3 and G4, interacting extensively with
the b-sheet residues, whereas the 30-end nucleotides
stretched away and made no interaction with RRM2.
The single-stranded DNA (strand I), bound to RRM2
monomer a, further interacted with the DNA (strand
III) that was bound to the neighboring RRM2 molecule
(monomer c), forming a double-stranded-like conforma-
tion (Figure 5). Watson–Crick base pairs were formed
between G6 and C7 of strand I and III. A5 of strand I
also interacted with G8 of strand III, whereas T9 of strand
I was stacked with G4 of strand III. These interactions
likely stabilized the crystal packing between RRM2–
DNA complexes and therefore led to the successful crys-
tallization of a high-resolution crystal.
Specific interactions between TDP-43 and TG sequence
Why does TDP-43 prefer to bind TG-rich and UG-rich
sequences? The interactions between RRM2 and DNA are
schematically displayed in Figure 5B. The three 50-end
nucleotides, particularly T3 and G4, played the key
role in the interactions. The thymine of T3 made three
hydrogen bonds to RRM2: O4 forming hydrogen bonds
with Ser258 (Og); N3 with Asn259 (backbone O); O2 with
Glu261 (backbone N). Besides hydrogen bonding, Phe194
and Phe231, the two aromatic residues conserved in RNP2
and RNP1 segments, also stacked or formed van der
Waals’ interactions with thymine of T3 (Figure 5C). The
guanine of G4 made four hydrogen bonds with RRM2:
N7 and O6 with Lys192 (Nz), and N1 and N2 with Glu261
(backbone O). The aromatic side chain of Phe221 and
Phe231 stacked or formed van der Waals’ interactions
with the guanine of G4.
By replacing the thymine T3 with a uracil and a cyto-
sine, we modeled a uracil and a cytosine bound at the
T3-binding pocket. We found that a cytosine can make
optimally two hydrogen bonds with RRM2, instead of
three hydrogen bonds originally identiﬁed with thymine.
On the contrary, a uridine at the same location may form
optimally three hydrogen bonds with RRM2, providing a
structural basis for the speciﬁc uridine preference in this
pocket (Figure 5D). Similarly, we replaced the guanine
Figure 4. Crystal structure of RRM2–DNA complex. (A) A ribbon model of RRM2 dimer bound to single-stranded DNAs. Molecule a (in blue) is
related to molecule b (in red) by a 2-fold crystallographic symmetry axis. DNA molecules are displayed as stick models. A classical RRM domain
contains four b-strands (b2-b3-b1-b5) as marked by the rectangle on the top of the structure; however, TDP-43 RRM2 has an extra b4 strand next to
b5. (B) A pair of hydrogen bonds are formed between the main-chain atoms of Asp247 (Asp247-O to Asp247-N), and a pair of hydrogen bonds are
formed between Glu245 (Oe2) and Ile249 (N) between the two antiparallel b4 strands to stabilize the RRM2 dimeric structure. (C) The RRM2
domain (monomer a) also interacts with the neighboring 2-fold symmetry-related molecule (monomer e). This view is rotated  90 degrees vertically
to that of panel A. (D) Four hydrogen bonds were formed between monomer a and e: Gln209 (Ne2) to Cys212 (O), and Glu208 (Oe1) to Cys (Sg).
1804 Nucleic Acids Research, 2009, Vol. 37,No. 6base in G4 with an adenine, and found that the possible
hydrogen bond number was reduced from 4 to 1. This
study thus elucidates the structural basis of TG- and
UG-preference of TDP-43 in DNA/RNA binding.
RRM2 domainforms ahighly thermal-stable assembly
The RRM2 dimer (monomers a and b) observed in the
crystals should be highly stable since a 10-stranded anti-
parallel b-sheet was formed in the dimer. To examine the
thermal stability of the TDP-43 truncated proteins, ther-
mal denaturation experiments were carried out and the
melting of b-strand structure was monitored by CD at
218nm (Figure 6). TDP-43s had a melting point of
49.7 0.98C, whereas RRM1 had a comparable melting
temperature of 49.5 0.78C in 200mM NaCl at pH 7.0.
However, the RRM2 was not melted with retained
b-strand structure up to 858C, suggesting that its melting
point was increased by more than 358C as compared to
those of TDP-43s and RRM1. This result shows that
RRM2 forms a highly stable structure and that it has
distinct biophysical properties as compared to TDP-43s
and RRM1.
A close look at the crystal packing of RRM2–DNA
complexes further shows that RRM2 dimers were assem-
bled into a ﬁbril-like solenoid structure (Figure 6C).
The dimeric TDP-43 RRM2 was packed against the
neighboring 2-fold-symmetry related dimers through the
interactions between the b2 strands and a1 helices. Each
RRM2 domain used the b4 strand on one edge of the
b-sheet to interact with the RRM2 domain within the
dimer, whereas it used the a1/b2 on the other edge of
Figure 5. Interactions between TDP-43 RRM2 and DNA. (A) Single-stranded DNA bound to RRM2 formed a double-stranded-like conformation,
with the DNA bound to the neighboring RRM2 molecule. Four RRM2–DNA complexes are shown here to demonstrate the interactions between
DNA strand I (bound to molecule a) and strand III (bound to molecule c). (B) Schematic diagrams of the detailed contacts between RRM2 and
DNA. Hydrogen bonds are shown by blue dotted line, and non-bonded contacts are shown by red dotted line. Watson–Crick base pairs were formed
between G6 and C7 (indicated by solid line) of strand I and III. (C) Extensive hydrogen-bond networks and non-bonded interactions are identiﬁed in
the T3-binding pocket (left) and G4-binding pocket (right) in TDP-43 RRM2–DNA crystal structure The bases of T3 and G4 stack with Phe194 and
Phe231, respectively. (D) A uracil (U3, left) and a cytosine (C3, middle) are modeled at the T3-binding pocket, whereas an adenine is modeled at the
G4 pocket (A4, right).
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dimers. The 10-stranded b-sheets in the RRM2 dimer
thus were wrapped into a left-handed super helix with
a-helices buried inside forming the hydrophobic core.
This ‘super-helix’ had diameters of 36A ˚ and 28A ˚ with a
helical pitch of 41A ˚ (Figure 6C). Although it remains
unclear why RRM2 domain was more resistant to thermal
denaturation, the structural study suggests that the high
melting point of RRM2 was likely due to protein dimer-
ization and formation of higher order thermal-stable
assemblies.
DISCUSSION
BothRRM1 andRRM2 of TDP-43 areinvolved in
site-specific DNA/RNA interactions
About 2% of the gene products in humans contain at least
one RNA recognition motif (RRM), making RRM one of
the most abundant protein domains (23). Most RRM pro-
teins have two to six copies of RRMs, which are folded
into an ab sandwich structure with a four b-stranded
pleated sheet packed against two a-helices. Crystal struc-
tures of a number of RRM proteins containing two
tandem RRM motifs, in a way similar to TDP-43, have
been reported, including hnRNP A1 (27,28), Hud (29), Sxl
(30), PABP (31) and FIR (32). hnRNP A1 forms a dimer
when it is bound with single-stranded nucleic acids,
whereas Hud, Sxl and PABP are monomers with similar
relative domain arrangement between RRM1 and RRM2.
The superposition of TDP-43 RRM2 domain onto the
RRM2 domain of two representative RRM proteins,
hnRNP A1 dimer (PDB entry code: 1U1O) and Hud
monomer (PDB entry code: 1FXL), showed that the
RRM2 domains in these proteins share a similar RRM
fold, except that TDP-43 RRM2 has an extra b4 strand
that is absent in hnRNP A1 and Hud (Figure 7).
The superposition of TDP-43 onto hnRNP A1 further
shows that the single-stranded nucleic acid molecules are
all bound to the b-sheet of RRMs at similar locations
(displayed as a tube in Figure 7). The thymine in T3 is
bound to a binding pocket in TDP-43 and this pocket is
also identiﬁed in hnRNP A1, HuD and Sxl where it binds
to adenine, uracil and guanine, respectively (Figure 7D).
Diﬀerent hydrogen-bonding networks and non-bonded
interactions diﬀerentiate the binding speciﬁcity of these
RRM proteins. The two aromatic residues, Phe231 (con-
served in RNP1) and Phe194 (conserved in RNP2), are
involved in stacking with T3. Previous mutational studies
showed that the conserved Phe residues in RRM1 of
TDP-43 play a key role in nucleic-acid recognition (8).
Therefore the RRM1 domain of TDP-43 likely interacts
with nucleic acids, particularly with TG-rich sequence, in
a way similar to that of RRM2 domain.
However, the G4 guanine-binding pocket identiﬁed in
TDP-43 is only found in hnRNP1 A1 but not in HuD, Sxl
and PABP, indicating that TDP-43 is structurally more
closely related to hnRNP1 A1 (Figure 7E). Our biochem-
ical data ﬁrst suggest that TDP-43 is a homodimer con-
taining four copies of RRM. Secondly, TDP-43 shares not
only an identical domain organization with two RRM
followed by a glycine-rich domain and also the highest
Figure 6. The RRM2 domain of TDP-43 forms a highly thermal-stable assembly as monitored by CD. (A) Thermal denaturation of TDP-43s,
RRM1 and RRM2, was assayed by CD from 25 to 858C in 200mM NaCl at pH 7.0. (B) The melting point, monitored at a wavelength of 218nm,
was 49.7 0.98C for TDP-43s, and 49.5 0.78C for RRM1. RRM2 was not melted up to 858C, suggesting that it was highly stable and had a melting
point greater than 858C. (C) The stereo view of the crystal packing of RRM2 shows that the RRM2 dimers interact with the neighboring dimers to
generate a left-handed super-helix structure. For clarity, DNA molecules have been removed and two super helices packed side by side are shown
here.
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43 shares the closest structural similarity in nucleic-acid
binding with hnRNP1. Therefore, based on these three
lines of evidence, we suggest that TDP-43 forms a homo-
dimer with a domain arrangement similar to that of
hnRNP A1. Also similar to hnRNPA1, both RRM1 and
RRM2 are involved in nucleic-acid interactions.
TDP-43 RRM2 domainhas aunique atypical
dimeric interface
Comparison of the protein interfaces among RRM family
proteins, we notice that the dimeric interface between
the two RRM2 domains is exclusively observed only in
the crystal structure of TDP-43 RRM2–DNA complex.
In hnRNP A1, the monomer containing RRM1–RRM2
is packed against the other monomer in an antiparallel
orientation, so that RRM1 interacts with RRM2 intermo-
lecularly and intramolecularly (Figure 7A). In Hud, Sxl
and PABP, RRM1 is packed against RRM2 of the same
molecule using a diﬀerent interface. However, the RRM2
domain in TDP-43 has a unique dimeric interface that has
not been observed previously among other RRM proteins.
This dimeric interface between the two RRM2 domains
in TDP-43 is unique since it is formed by the b4 strand
that is only present in TDP-43 but not in other RRM
proteins. We further show that the melting point of
RRM2 domain was greater than 858C, at least 358C
higher than that of TDP-43s (49.7 0.98C) and RRM1
(49.5 0.78C), suggesting that RRM2 was assembled
into a thermal-stable structure, that must be diﬀerent
from the native state. It remains unclear whether the atyp-
ical dimerization of the RRM2 domains are related to
the pathogenic inclusions of TDP-43 C-terminal frag-
ments observed in FTLD and ALS (for a recent review,
see (33)). This well-organized thermal-stable RRM2
dimeric structure thus oﬀers a testable model for the
Figure 7. Comparison of RRM domain assembly between TDP-43, hnRNP A1 and HuD. (A) The RRM2 domain of TDP-43 (in red) was super-
imposed onto the RRM2 of hnRNP A1. hnRNP A1 is a homodimer (in yellow and gray) bound to two strands of RNA (schematically displayed as
a navy blue tube). The DNA bound to TDP-43 is displayed in green. (B) The RRM2 of TDP-43 (red) was superimposed onto the RRM2 of HuD
(yellow). All the RRM2 domains in hnRNP A1, HuD and TDP-43 were ﬁxed in the same orientation as marked by a black frame. (C) The dimeric
interface in the TDP-43 RRM2 dimer is atypical, compared to those found in hnRNP A1 and HuD. (D) A similar T3-binding pocket was identiﬁed
in several RRM proteins: TDP-43 in red (bound to T3); hnRNP A1 in navy blue (bound to A209); HuD in green (bound to U3); and Sxl in orange
(bound to G4). (E) A similar G4 binding pocket in TDP-43 (in red) was only identiﬁed in hnRNP A1 (in navy blue, bound to G210). The PDB entry
codes of the structures used in this ﬁgure are: 1U1O for hnRNP A1, 1FXL for HuD and 1B7F for Sxl.
Nucleic Acids Research,2009, Vol.37, No. 6 1807study of the pathogenic aggregates in the group of neuro-
degenerative diseases known as TDP-43 proteinopathies.
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